Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for Esophageal Hypomotility
NCT01448993Phase 2Completed
- Start
- Aug 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azithromycin in esophageal motility disorder (EMD). Started Aug 2012; status: completed.
02
Drugs
azithromycin
03
Conditions
esophageal motility disorder (EMD)
Beyond the preview
Go deeper on NCT01448993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01448993.